-
-
-
-
-
-
-
Goldman Sachs Starts Guardant Health (GH) at Buy
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Guardant Health (GH) Following G360 Liquid FDA Approval
-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Guardant Health (GH)
-
-
-
-
-
-
-
Baird Starts Guardant Health (GH) at Outperform
-
-
-
-
-
-
-
Guardant Health launches liquid biopsy testing at Italian hospital
-
-
-
-
-
-
-
Guardant Health (GH) PT Raised to $100 at BTIG, Top Pick
-
-
-
-
-
-
-
Guardant Health (GH) PT Raised to $67 at Guggenheim
-
423,329 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

